In 
        Enterobacterales bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d.

Konstantinos Ouranos; Eleftherios Mylonakis

doi:10.7326/J24-0030

In Enterobacterales bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d.

Konstantinos Ouranos, Eleftherios Mylonakis

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

López-Cortés LE, Delgado-Valverde M, Moreno-Mellado E, et al; SIMPLIFY study group. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis. 2024;24:375-385. 38215770.

Original language	English (US)
Pages (from-to)	JC52
Journal	Annals of Internal Medicine
Volume	177
Issue number	5
DOIs	https://doi.org/10.7326/J24-0030
State	Published - May 1 2024

Keywords

beta-Lactams/therapeutic use
Drug Administration Schedule
Enterobacteriaceae Infections/drug therapy
Humans
Enterobacteriaceae/drug effects
Middle Aged
Male
Female
Bacteremia/drug therapy
Aged
Anti-Bacterial Agents/therapeutic use

ASJC Scopus subject areas

Internal Medicine

Divisions

Infectious Disease

Access to Document

10.7326/J24-0030

Cite this

@article{8ac77105acc7484d832fc5740d4663ea,

title = "In Enterobacterales bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d.",

abstract = "L{\'o}pez-Cort{\'e}s LE, Delgado-Valverde M, Moreno-Mellado E, et al; SIMPLIFY study group. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis. 2024;24:375-385. 38215770. ",

keywords = "beta-Lactams/therapeutic use, Drug Administration Schedule, Enterobacteriaceae Infections/drug therapy, Humans, Enterobacteriaceae/drug effects, Middle Aged, Male, Female, Bacteremia/drug therapy, Aged, Anti-Bacterial Agents/therapeutic use",

author = "Konstantinos Ouranos and Eleftherios Mylonakis",

year = "2024",

month = may,

day = "1",

doi = "10.7326/J24-0030",

language = "English (US)",

volume = "177",

pages = "JC52",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "5",

}

TY - JOUR

T1 - In Enterobacterales bacteremia, antipseudomonal β-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d.

AU - Ouranos, Konstantinos

AU - Mylonakis, Eleftherios

PY - 2024/5/1

Y1 - 2024/5/1

N2 - López-Cortés LE, Delgado-Valverde M, Moreno-Mellado E, et al; SIMPLIFY study group. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis. 2024;24:375-385. 38215770.

AB - López-Cortés LE, Delgado-Valverde M, Moreno-Mellado E, et al; SIMPLIFY study group. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial. Lancet Infect Dis. 2024;24:375-385. 38215770.

KW - beta-Lactams/therapeutic use

KW - Drug Administration Schedule

KW - Enterobacteriaceae Infections/drug therapy

KW - Humans

KW - Enterobacteriaceae/drug effects

KW - Middle Aged

KW - Male

KW - Female

KW - Bacteremia/drug therapy

KW - Aged

KW - Anti-Bacterial Agents/therapeutic use

UR - https://www.scopus.com/pages/publications/85194013137

UR - https://www.scopus.com/inward/citedby.url?scp=85194013137&partnerID=8YFLogxK

U2 - 10.7326/J24-0030

DO - 10.7326/J24-0030

M3 - Article

C2 - 38710092

AN - SCOPUS:85194013137

SN - 0003-4819

VL - 177

SP - JC52

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 5

ER -